Repare Therapeutics

Biotechnology
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company’s focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.

$75.8M

Market Cap • 9/18/2025

2016

(9 years)

Founded

2020

(5 years ago)

IPO

NASDAQ

Listing Exchange

Flag of Canada

Canada

Country